Certara Scientists are Among the Topmost Cited Biopharma Researchers Press Release Certara Scientists are Among the Topmost Cited Biopharma Researchers Certara celebrates its 200 published papers and 11 scientists ranked in the top 2% of…CertaraOctober 20, 2025
Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results Publication Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…CertaraOctober 15, 2025
RAPS Sponsored Webinar: Planning and Preparing Regulatory Submissions Using Top-down Messaging On-Demand Webinar RAPS Sponsored Webinar: Planning and Preparing Regulatory Submissions Using Top-down Messaging Access our on-demand webinar and explore proven strategies to develop consistent, high-impact regulatory submission messages.CertaraOctober 9, 2025
MBMA vs. Meta-Analysis: Quick Comparison Guide Guide MBMA vs. Meta-Analysis: Quick Comparison Guide Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…CertaraOctober 8, 2025
U.S. International Reference Pricing: Global Implications and Pharma Strategy Blog U.S. International Reference Pricing: Global Implications and Pharma Strategy Unintended global fallout of international reference pricing: How the U.S. Most Favored Nation policy could…CertaraOctober 6, 2025
Highlights from the FDA Guidance on Dosage Optimization for Therapeutic Radiopharmaceuticals Video Highlights from the FDA Guidance on Dosage Optimization for Therapeutic Radiopharmaceuticals Learn how radiopharmaceutical therapies work in oncology and how Certara supports development with modeling, simulation,…CertaraOctober 3, 2025
How Certara and TrialAssure Partner to Deliver Faster, Compliant Anonymization for Global Sponsors Case Study How Certara and TrialAssure Partner to Deliver Faster, Compliant Anonymization for Global Sponsors Discover how Certara's partnership with TrialAssure provides global sponsors with accelerated, compliant, and enhanced document…CertaraOctober 3, 2025
Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer Case Study Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…CertaraOctober 2, 2025